• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Neurocrine Biosciences

Neurocrine Biosciences

Neurocrine Biosciences Inc NBIX

Last Price$51.42Day Change (%)-3.64%
Open Price$53.37Day Change ($)-1.94
Day Range50.41–53.5452-Week Range31.25–58.46

As of Wed 9/28/2016 5:14:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Global Tourette Syndrome Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts - Key Vendors: Neurocrine Biosciences , Otsuka Holdings, Pfizer - Research and Markets

    Global Tourette Syndrome Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts - Key Vendors: Neurocrine Biosciences , Otsuka Holdings, Pfizer - Research and Markets

  2. CLS: Slow Down, Think Before You Trade

    On Monday, Neurocrine Biosciences NBIX accelerated its anticipated filing date for indiplon capsules to the second quarter of 2007 instead of 2009. We're placing Neurocrine under review while we revisit our assumptions, and because DOV Pharmaceutical DOVP is entitled to a royalty on any indiplon ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.